 |
|
||
Dr. Drew Mihalyo is a past winner of the Pharmacy Times and Parata Systems Next Generation Pharmacist Technology Innovator Award.
For most of his professional career, he brought an entrepreneurial spirit; fervor for technology and innovation; and an unyielding focus on quality care, quality outcomes, and transparent pricing to his role as Founder, President, and Chief Operating Officer of Delta Care Rx - now the Pharmacy services component of Dragonfly Health. He continues to serve as a strategic consultant and champion for the organization to date.
Under Dr. Mihalyo’s energetic direction, Delta Care became a pharmacy benefit management company—and much more—serving hospice and palliative care providers large and small, urban and rural, all across the country. Early on, Delta Care revolutionized the relationship between hospice providers and pharmacy benefit managers through its ground-breaking pricing model.
Dr. Mihalyo developed and introduced the nation’s first “hospice-tailored” e-Prescribing platform in 2010, transforming how hospice providers manage patient symptoms and pain and revolutionizing how hospice administrators manage their pharmacy spend. To this day, most e-Prescriptions nationally in hospice care are sent from hospice pharmacy fostered technologies rather than EMR systems. Such paves the way and allows for a heightened pharmacist provision of care to be present in end of life care processes.
In addition, he has led development and implementation of a comprehensive suite of distinctive products and services offered for the benefit of hospices, including but not limited to 24/7/365 real-time live access to clinical pharmacists, development of customized preferred drug lists, delivery of niche’ reports to meet all pharmacy-related goals and regulations, telehealth, and a robust no-cost continuing education curriculum for hospice clinicians.
His other professional interests include the management of self-insured or commercial drug plans, Rx rebate management, healthcare innovation, systems interoperability, the development and widespread adoption of telemedicine, a successful path towards a robust technology platform for dual management of both pharmacy and DME, accountable care, and effective networking among healthcare providers, clinicians, vendors and suppliers, academic institutions, patient advocates, and policymakers.
Dr. Mihalyo began his career as a retail pharmacist in the Pittsburgh area while building out his career forward in serious illness.
He received his Doctor of Pharmacy from the Duquesne University Mylan School of Pharmacy, Pittsburgh, Pennsylvania. He has completed the highly regarded Education in Palliative and End-of-Life Care (EPEC) Curriculum as developed by the Northwestern University Feinberg School of Medicine.
Crafting additional means of innovation and efficiency for the broader serious illness management sector remains a passion of his.